|
|
PVCT Provectus Biopharmaceuticals
|
|
||
Amazed and baffledhttps://www.theglobeandmail.com/business/article-ventus-therapeutics-deal-novo-nordisk/ This company, has a new molecule for inflammation. No human trials as of yet. It just looks promising. Don’t they have to gather years of clinical data before BP is interested.? That’s the story that has been sold here. We need more data before deals can be made. Year after year. There’s something wrong. I don’t mean the product. It’s obvious it works. I’m sold on it. Cancer institutes like it. Researchers like it, etc. But the money side of the industry does nothing. PV10 is so far past “promising” it’s ridiculous. So here we sit, looking at a reverse split. Some posters actually cheerleading it, when historically it will destroy their investment. |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
6714 | Re: Amazed and baffled | LurkeyTurkey | 2 | 10/6/2022 8:37:06 AM |